Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Recently, Zacks.com users have been paying close attention to Hologic ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Hologic has obtained a CE mark in Europe for Affirm, its contrast biopsy software for use in contrast-enhanced mammography (CEM). Affirm facilitates the targeting and acquisition of tissue samples ...

Designed from the ground up to integrate with the Selenia ® Dimensions ® and 3Dimensions™ systems, Hologic’s Affirm Contrast Biopsy Software enables clinicians to target and acquire tissue ...

Citi lowered the firm’s price target on Hologic (HOLX) to $70 from $80 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape ...